Norway· NO-ID_02BFA002-4585-4761-9A13-DF3FD4153D57
Picibanil
A antineoplastic agents product, registered in Norway by Chugai Pharmaceutical. The same ATC class is registered in 6 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Picibanil is registered in 6 of 19 countries.
Countries holding a registration under ATC L01 (antineoplastic agents), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 3 of them publish a price we can compare per daily dose
Picibanil · ATC L01
6 / 19 countries
- Canada
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
FEST (Norway)- Manufacturer
- Chugai Pharmaceutical
- Country
- Norway (NO)
- ATC code
- L01
- ATC class
- ANTINEOPLASTIC AGENTS
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 2
- no_merkevare_idID_02BFA002-4585-4761-9A13-DF3FD4153D57
- no_varenummer2849611
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L01
Antineoplastic agents, as other registers publish it.
- IrelandAbecma 260 - 500 x 106 cells dispersion for infusionBristol-Myers Squibb Pharmaceuticals uc
- NetherlandsAkeega 100 mg/500 mg filmomhulde tablettenJanssen-Cilag International NV
- NetherlandsAkeega 50 mg/500 mg filmomhulde tablettenJanssen-Cilag International NV
- CanadaASPARLASSERVIER CANADA INC
- IrelandBreyanzi 1.1-70 x 10^6 cells/mL/1.1-70 x 10^6 cells/mL dispersion for infusionCelgene Europe B.V.
- IrelandELREXFIO 40 mg/mL solution for injectionPfizer Europe MA EEIG
- IcelandKimmtrakImmunocore Ireland Limited
- IrelandKIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusionImmunocore Ireland Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e891eace-279a-456b-b1c9-b6b6fdb8fa51 GET /v1/drugs/e891eace-279a-456b-b1c9-b6b6fdb8fa51?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjonsvæske, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Antineoplastiske midler",
"merkevare_id": "ID_02BFA002-4585-4761-9A13-DF3FD4153D57",
"name_form_strength": "Picibanil pulv+væske til inj susp 0,1 mg",
"prescription_group": "C"
}See everything about Picibanil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.